Samples Procurement for Colorectal Cancer, Gastric Cancer, and Non-malignant Disease

Colorectal Cancer Clinical Trial

Official title:

Samples Procurement for Patients With Colorectal Cancer, Gastric Cancer, and Non-malignant Disease Undergoing Surgery

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03972956
• Other study ID #: SAMPGICUS
• Status: Recruiting
• Start date: December 23, 2020
• Est. completion date: December 23, 2026

Study information

• Verified date: April 2022
• Source: Renmin Hospital of Wuhan University
• Contact: Tao Fu, MD
• Phone: +8613720120190
• Email: tfu001[@]whu.edu.cn
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purposes of this study are to collect and store samples including blood, normal and tumor tissue from patients with colorectal cancer or gastric cancer, to collect and store samples including blood and/or normal gastrointestinal tissue (if available) from patients with non-malignant disease (including, but not limited to, inflammatory bowel disease (IBD), gastric ulcer, hemorrhoids or hernia), and to create a database for the collected samples and allow access to relevant clinical information for current and future protocols.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1000
• Est. completion date: December 23, 2026
• Est. primary completion date: December 23, 2023
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

• Any patient diagnosed with colorectal cancer, gastric cancer, non-malignant disease that requires undergoing surgery.

• Must be willing and able to provide informed consent.

Exclusion Criteria:

• Subjects whose comorbidities would preclude diagnostic or therapeutic intervention.

Related Conditions & MeSH terms

• Colorectal Cancer
• Colorectal Neoplasms
• Gastric Cancer
• Gastric Ulcer
• Hemorrhoids
• Hernia
• Inflammatory Bowel Diseases
• Stomach Neoplasms
• Stomach Ulcer

Intervention

Other:
• No intervention will be given to patients.
Samples are collected at the time of a scheduled surgery that is part of normal treatment. This study will not have any impact on the care or treatment the patient receives.

Locations

Country	Name	City	State
China	Department of Gastrointestinal Surgery II, Renmin Hospital of Wuhan University	Wuhan	Hubei

Sponsors (1)

Lead Sponsor	Collaborator
Renmin Hospital of Wuhan University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Confirmation of diagnosis by pathologist	Once tissue is collected, those samples that have a confirmed diagnosis of disease by the pathologist will be used.	Up to 3 years